Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
16.20
-0.95 (-5.54%)
Oct 13, 2026, 11:49 AM EDT - Market open

Seaport Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
64.2246.04309.1
Short-Term Investments
209.09169.94-
Cash & Short-Term Investments
273.31215.98309.1
Cash Growth
--30.13%-
Other Receivables
4.863.03-
Receivables
4.863.03-
Prepaid Expenses
2.251.180.39
Other Current Assets
1.763.040.66
Total Current Assets
282.18223.23310.15
Property, Plant & Equipment
5.15.235.17
Long-Term Investments
153.9517.67-
Long-Term Deferred Charges
-1.2-
Other Long-Term Assets
0.451.680.45
Total Assets
441.68249.01315.78

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
5.712.014.73
Accrued Expenses
8.369.135.21
Current Portion of Leases
1.611.640.86
Other Current Liabilities
-0.010.35
Total Current Liabilities
15.6712.7811.15
Long-Term Leases
3.413.444.15
Total Liabilities
19.0816.2315.3

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.0100
Additional Paid-In Capital
625.1921.2614.38
Retained Earnings
-202.12-114.11-39.23
Comprehensive Income & Other
-0.480.3-
Total Common Equity
422.6-92.55-24.85
Shareholders' Equity
422.6232.78300.48
Total Liabilities & Equity
441.68249.01315.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
5.025.085.01
Net Cash (Debt)
268.29210.9304.09
Net Cash Growth
--30.65%-
Net Cash Per Share
16.9328.29102.68
Filing Date Shares Outstanding
53.538.158.15
Total Common Shares Outstanding
53.538.158.15
Working Capital
266.5210.45299
Book Value Per Share
7.89-11.35-3.05
Tangible Book Value
422.6-92.55-24.85
Tangible Book Value Per Share
7.89-11.35-3.05
Machinery
0.970.970.98
Leasehold Improvements
0.430.430.1
SEC Filings: 10-K · 10-Q